H.B. 1488 adds rheumatoid arthritis, lupus, epilepsy, and multiple sclerosis to the list of qualifying conditions and allows patients and caregivers to access testing facilities. Patients and caregivers will be allowed to cultivate three additional plants of any maturity, for a total of 10 plants. The phasing out of caregivers’ ability to grow marijuana plants for patients has been pushed back five years, to the end of 2023.
The new law, which goes into effect on June 29, also authorizes the Department of Health to permit current licensees to open one additional dispensary — for a possible total of 24 statewide — and allows them to cultivate more plants at their production sites. It also amends certain deadlines and relaxes overly restrictive laboratory standards to accelerate implementation.
With the updated regulations, laboratories should find it easier to meet the requirements for certification. Several dispensaries are ready to start serving patients but cannot do so until they can submit their products for the required testing.
Congratulations and thank you to Gov. Ige, the Drug Policy Forum of Hawaii, and all of the advocates and lawmakers who made these improvements possible.